With great frustration, many find that they are unable to tap into a cohesive set of data that provides a complete and current view into their portfolio.
With great frustration, many find that they are unable to tap into a cohesive set of data that provides a complete and current view into their portfolio.
Unprofitable BU’s or non-core product lines are being aggressively wound down, and the associated IP (now stranded) is increasingly being looked at in efforts to extract any remaining value.
Not only are companies engaged in trying to sell or license their inventions, but they are also being approached by third party entities interested in buying specific patents.
Increasingly, packaging breakthroughs are occurring outside of the R&D labs at large established players and are taking place in smaller, more nimble firms.
However, companies in this industry frequently struggle to capitalize on their inventions beyond the immediate application for which they were developed.